Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Medicine, Placebo, Internal medicine, Thyroid cancer, Tolerability, and Type 2 diabetes.
536MO SHR-A1811 plus pertuzumab in human epidermal growth factor receptor 2-positive (HER2+) unresectable/metastatic breast cancer: Results from a phase Ib/II study
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
Selenium and thyroid diseases
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro
Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies